Latest News

ACTO Named Among Everest Group's Top 50™ Pharmaceutical Technology Providers for 2026

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote “FOR” All Six of Anavex’s Highly Qualified Director Nominees

ACTO figure dans le Top 50™ des fournisseurs de technologies pharmaceutiques établi par Everest Group pour 2026

Cardiff Oncology and Nerviano Medical Sciences Amend their 2017 Exclusive License Agreement

Reliance Global Group Completes Sale of Southwestern Montana Insurance Center for $2.625 Million in Cash at Closing Plus Uncapped Earnout

NewtekOne, Inc. Declares Dividends on Common Stock and Series B Preferred Shares

Eos Energy Enterprises Receives $87 Million Advance Under U.S. Department of Energy Loan to Fund Second Production Line at Thorn Hill

INVESTOR DEADLINE: Alibaba Group Holding Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before October 5, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - BABA

Value-Based Healthcare Services Market Size to Hit USD 166.72 Billion by 2035, Growing at a CAGR of 9.14% - SNS Insider

Leonardo DRS Extends Naval Aviation’s Communications Edge With $39.6 Million JTT-X Production Award